Research & Literature

Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Iraqi M, Perdomo J, Yan F, et al.

Haematologica 2015; (100(5)):623-32 doi:10.3324/haematol.2014.115634.

High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.

Kim CY, Lee EH, Yoon HS

Yonsei medical journal 2016; (57(1)):127-31 doi:10.3349/ymj.2016.57.1.127.

Bleeding complications in immune thrombocytopenia.

Arnold DM

Hematology. American Society of Hematology. Education Program 2015; (2015()):237-42 doi:10.1182/asheducation-2015.1.237.

Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines.

Witmer CM, Lambert MP, O'Brien SH, Neunert C

Pediatric blood & cancer 2016; (63(7)):1227-31 doi:10.1002/pbc.25961.

Re-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia Contributors.

Purohit A, Aggarwal M, Singh PK, et al.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2016; (32(2)):193-6 doi:10.1007/s12288-015-0533-2.

Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.

Lozano ML, Revilla N, Gonzalez-Lopez TJ, et al.

Annals of hematology 2016; (95(7)):1089-98 doi:10.1007/s00277-016-2665-3.

Controversies in the treatment of immune thrombocytopenia.

Cuker A, Cines DB, Neunert CE

Current opinion in hematology 2016; (23(5)):479-85 doi:10.1097/MOH.0000000000000270.

Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy.

Sun D, Shehata N, Ye XY, et al.

Blood 2016; (128(10)):1329-35 doi:10.1182/blood-2016-04-710285.

Advances in Diagnosis and Treatments for Immune Thrombocytopenia.

Nomura S

Clinical medicine insights. Blood disorders 2016; (9()):15-22 doi:10.4137/CMBD.S39643.

Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.

Lai SW, Lin HF, Lin CL, Liao KF

Internal and emergency medicine 2017; (12(2)):157-162 doi:10.1007/s11739-016-1520-9.

Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.

Chotsampancharoen T, Sripornsawan P, Duangchoo S, et al.

Pediatric blood & cancer 2017; (64(1)):128-134 doi:10.1002/pbc.26178.

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.

Scully M, Cataland S, Coppo P, et al.

Journal of thrombosis and haemostasis : JTH 2017; (15(2)):312-322 doi:10.1111/jth.13571.

Long-term complications of splenectomy in adult immune thrombocytopenia.

Thai LH, Mahévas M, Roudot-Thoraval F, et al.

Medicine 2016; (95(48)):e5098 doi:10.1097/MD.0000000000005098.

Second-line therapies in immune thrombocytopenia.

Grace RF, Neunert C

Hematology. American Society of Hematology. Education Program 2016; (2016(1)):698-706 doi:10.1182/asheducation-2016.1.698.

Thrombocytopenia and infections.

Franchini M, Veneri D, Lippi G

Expert review of hematology 2017; (10(1)):99-106 doi:10.1080/17474086.2017.1271319.

Primary versus secondary immune thrombocytopenia in adults; a comparative analysis of clinical and laboratory attributes in newly diagnosed patients in Southern Pakistan.

Sultan S, Ahmed SI, Murad S, Irfan SM

The Medical journal of Malaysia 2016; (71(5)):269-274.

Pathogenesis of immune thrombocytopenia.

Audia S, Mahévas M, Samson M, et al.

Autoimmunity reviews 2017; (16(6)):620-632 doi:10.1016/j.autrev.2017.04.012.

Neonatal Outcomes of Pregnancy with Immune Thrombocytopenia.

Melekoğlu NA, Bay A, Aktekin EH, et al.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2017; (33(2)):211-215 doi:10.1007/s12288-016-0708-5.

Management of adult primary immune thrombocytopenia based on Japanese clinical guides.

Tomiyama Y

[Rinsho ketsueki] The Japanese journal of clinical hematology 2017; (58(7)):843-848 doi:10.11406/rinketsu.58.843.

Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.

Bennett CM, Neunert C, Grace RF, et al.

Pediatric blood & cancer 2018; (65(1)) doi:10.1002/pbc.26736.

Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk.

McDonnell A, Bride KL, Lim D, et al.

Pediatric blood & cancer 2018; (65(2)) doi:10.1002/pbc.26812.

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry.

Arnold DM, Nazy I, Clare R, et al.

Blood advances 2017; (1(25)):2414-2420 doi:10.1182/bloodadvances.2017010942.

Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticosteroids and intravenous immunoglobulin: a prospective follow-up of suggested practice.

Wegnelius G, Bremme K, Lindqvist PG,

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(2)):141-147 doi:10.1097/MBC.0000000000000683.

Wiskott-Aldrich syndrome that was initially diagnosed as immune thrombocytopenic purpura secondary to a cytomegalovirus infection.

Kaneko R, Yamamoto S, Okamoto N, et al.

SAGE open medical case reports 2018; (6()):2050313X17753788 doi:10.1177/2050313X17753788.

A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

Rodeghiero F

British journal of haematology 2018; (181(2)):183-195 doi:10.1111/bjh.15090.

Successful Treatment of Aggressive Mature B-cell Lymphoma Mimicking Immune Thrombocytopenic Purpura.

Ono K, Onishi Y, Kobayashi M, et al.

Internal medicine (Tokyo, Japan) 2018; (57(17)):2573-2579 doi:10.2169/internalmedicine.0560-17.

[Idiopathic thrombocytopenia refractery to therapy of cyclosporine A in clinical practice - case report].

Schwarzová L, Pirník Z, Štecová N

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 2018; (66(5)):233-237.

Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.

Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, et al.

Blood 2018; (132(9)):883-891 doi:10.1182/blood-2018-02-830844.

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.

Piel-Julian ML, Mahévas M, Germain J, et al.

Journal of thrombosis and haemostasis : JTH 2018; (16(9)):1830-1842 doi:10.1111/jth.14227.

Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis.

Arai Y, Matsui H, Jo T, et al.

Platelets 2019; (30(8)):946-956 doi:10.1080/09537104.2018.1543864.

Immune thrombocytopenic purpura.

Zainal A, Salama A, Alweis R

Journal of community hospital internal medicine perspectives 2019; (9(1)):59-61 doi:10.1080/20009666.2019.1565884.

The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test.

Vrbensky JR, Moore JE, Arnold DM, et al.

Journal of thrombosis and haemostasis : JTH 2019; (17(5)):787-794 doi:10.1111/jth.14419.

Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.

Le Guenno G, Guieze R, Audia S, et al.

Internal medicine journal 2019; (49(9)):1154-1162 doi:10.1111/imj.14269.

Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.

Kohli R, Chaturvedi S

Hamostaseologie 2019; (39(3)):238-249 doi:10.1055/s-0039-1683416.

[TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN ADULTS: UPDATE].

Blickstein D

Harefuah 2019; (158(3)):196-199.

Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.

Adelborg K, Kristensen NR, Nørgaard M, et al.

Journal of thrombosis and haemostasis : JTH 2019; (17(6)):912-924 doi:10.1111/jth.14446.

Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.

Ekstrand C, Linder M, Baricault B, et al.

Thrombosis research 2019; (178()):124-131 doi:10.1016/j.thromres.2019.04.016.

Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit.

Liu J, Pavenski K, Sholzberg M

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2019; (58(4)):491-494 doi:10.1016/j.transci.2019.05.003.

An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.

Joly BS, Coppo P, Veyradier A

Expert review of hematology 2019; (12(6)):383-395 doi:10.1080/17474086.2019.1611423.

Managing ITP and thrombocytopenia in pregnancy.

Eslick R, McLintock C

Platelets 2020; (31(3)):300-306 doi:10.1080/09537104.2019.1640870.

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Provan D, Arnold DM, Bussel JB, et al.

Blood advances 2019; (3(22)):3780-3817 doi:10.1182/bloodadvances.2019000812.

American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Neunert C, Terrell DR, Arnold DM, et al.

Blood advances 2019; (3(23)):3829-3866 doi:10.1182/bloodadvances.2019000966.

Management of immune thrombocytopenia in women: current standards and special considerations.

Rodeghiero F, Marranconi E

Expert review of hematology 2020; (13(2)):175-185 doi:10.1080/17474086.2020.1711729.

Novel scientific approaches and future research directions in understanding ITP.

Hicks SM, Coupland LA, Jahangiri A, et al.

Platelets 2020; (31(3)):315-321 doi:10.1080/09537104.2020.1727871.

Management of major bleeds in patients with immune thrombocytopenia.

Mithoowani S, Cervi A, Shah N, et al.

Journal of thrombosis and haemostasis : JTH 2020; (18(7)):1783-1790 doi:10.1111/jth.14809.

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review.

Birocchi S, Podda GM, Manzoni M, et al.

Platelets 2021; (32(2)):216-226 doi:10.1080/09537104.2020.1745168.

Evolution and Utility of Antiplatelet Autoantibody Testing in Patients with Immune Thrombocytopenia.

Porcelijn L, Schmidt DE, Oldert G, et al.

Transfusion medicine reviews 2020; (34(4)):258-269 doi:10.1016/j.tmrv.2020.09.003.

Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.

Lozano ML, Godeau B, Grainger J, et al.

Expert review of hematology 2020; (13(12)):1319-1332 doi:10.1080/17474086.2020.1850253.

Plexus Slim®-Induced Immune Thrombocytopenic Purpura.

Graf C, Elmassry M, Chu VM, et al.

Cureus 2020; (12(11)):e11413 doi:10.7759/cureus.11413.

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.

Janssens A, Selleslag D, Depaus J, et al.

Acta clinica Belgica 2022; (77(2)):470-483 doi:10.1080/17843286.2021.1876310.

Update on diagnosis and treatment of immune thrombocytopenia.

Sandal R, Mishra K, Jandial A, et al.

Expert review of clinical pharmacology 2021; (14(5)):553-568 doi:10.1080/17512433.2021.1903315.

How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment.

Ghanima W, Gernsheimer T, Kuter DJ

Blood 2021; (137(20)):2736-2744 doi:10.1182/blood.2021010968.

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Cooper N, Altomare I, Thomas MR, et al.

Therapeutic advances in hematology 2021; (12()):20406207211010875 doi:10.1177/20406207211010875.

Exacerbation of immune thrombocytopenia following COVID-19 vaccination.

Kuter DJ

British journal of haematology 2021; (195(3)):365-370 doi:10.1111/bjh.17645.

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.

Audia S, Mahévas M, Nivet M, et al.

HemaSphere 2021; (5(6)):e574 doi:10.1097/HS9.0000000000000574.

A meta-analysis of neonatal outcomes in pregnant women with immune thrombocytopenic purpura.

Luo H, Li D, Gao F, et al.

The journal of obstetrics and gynaecology research 2021; (47(9)):2941-2953 doi:10.1111/jog.14890.

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.

Grainger JD, Kühne T, Hippenmeyer J, Cooper N

Annals of hematology 2021; (100(9)):2143-2154 doi:10.1007/s00277-021-04590-0.

Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology.

Sirotich E, Guyatt G, Gabe C, et al.

Journal of thrombosis and haemostasis : JTH 2021; (19(8)):2082-2088 doi:10.1111/jth.15368.

Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.

Lafaurie M, Maquet J, Baricault B, et al.

British journal of haematology 2021; (195(3)):456-465 doi:10.1111/bjh.17709.

Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern.

Cuker A, Liebman HA

Research and practice in thrombosis and haemostasis 2021; (5(6)):e12592 doi:10.1002/rth2.12592.

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.

Lee EJ, Beltrami-Moreira M, Al-Samkari H, et al.

Blood 2022; (139(10)):1564-1574 doi:10.1182/blood.2021013411.

Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.

Choi PY, Merriman E, Bennett A, et al.

The Medical journal of Australia 2022; (216(1)):43-52 doi:10.5694/mja2.51284.

Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment.

Mageau A, Terriou L, Ebbo M, et al.

American journal of hematology 2022; (97(1)):10-17 doi:10.1002/ajh.26378.

COVID-19 vaccination in patients with immune thrombocytopenia.

Visser C, Swinkels M, van Werkhoven ED, et al.

Blood advances 2022; (6(6)):1637-1644 doi:10.1182/bloodadvances.2021006379.

Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine.

Sivaramakrishnan P, Mishra M

BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2022-249237.

An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia.

Song AB, Al-Samkari H

Expert review of clinical immunology 2022; (18(8)):783-791 doi:10.1080/1744666X.2022.2098119.

Primary immune thrombocytopenia: a 'diagnosis of exclusion'?

Visweshwar N, Ayala I, Jaglal M, et al.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2022; (33(6)):289-294 doi:10.1097/MBC.0000000000001144.

Current approaches for the diagnosis and management of immune thrombocytopenia.

Anat GG

European journal of internal medicine 2023; (108()):18-24 doi:10.1016/j.ejim.2022.11.022.

Utilization of an ITP quality improvement pathway improves adherence to management guidelines.

Harris EM, Hillier K, Nolan M, et al.

Pediatric blood & cancer 2023; (70(3)):e30074 doi:10.1002/pbc.30074.

Advances in management of pediatric chronic immune thrombocytopenia: a narrative review.

Lee JM

Journal of Yeungnam medical science 2023; (40(3)):241-246 doi:10.12701/jyms.2022.00745.

The role of CD8+ T-cell clones in immune thrombocytopenia.

Malik A, Sayed AA, Han P, et al.

Blood 2023; (141(20)):2417-2429 doi:10.1182/blood.2022018380.

Reticulated Platelet Count as a Diagnostic Tool in Immune Thrombocytopenia (ITP).

Butt AJ, Zaidi U, Munawar Ali R, et al.

Cureus 2023; (15(7)):e41346 doi:10.7759/cureus.41346.

Characteristics and outcomes of COVID-19 in Chinese immune thrombocytopenia patients: A prospective cohort study.

Chen Y, Liu J, Shao S, et al.

British journal of haematology 2024; (204(4)):1207-1218 doi:10.1111/bjh.19198.

Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed systemic lupus erythematosus.

Bruns L, Völker L, Klamroth R, et al.

Clinical nephrology. Case studies 2023; (11()):147-153 doi:10.5414/CNCS111193.

Immune attack on megakaryocytes in immune thrombocytopenia.

Petito E, Gresele P

Research and practice in thrombosis and haemostasis 2024; (8(1)):102345 doi:10.1016/j.rpth.2024.102345.

The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study.

Fu H, Cai X, Cui L, et al.

Annals of hematology 2024; (103(5)):1549-1559 doi:10.1007/s00277-024-05720-0.

Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia in a Patient with Seronegative Arthritis: A Case Report.

Arvind MN, Rajanna AH, Kamath N

The Journal of the Association of Physicians of India 2023; (71(11)):100-102 doi:10.59556/japi.71.0386.

Is it possible to predict morbidities in neonates born to mothers with immune thrombocytopenic purpura?: A retrospective cross-sectional study.

Aslan MT, İnce Z, Bilgin L, et al.

Medicine 2024; (103(25)):e38587 doi:10.1097/MD.0000000000038587.

Epidemiology, Treatment Patterns, and Cost Analysis of Immune Thrombocytopenia in Spain between 2014 and 2020: A Population-based Study.

González-López TJ, Alperovich G, Burillo E, et al.

TH open : companion journal to thrombosis and haemostasis 2024; (8(3)):e252-e265 doi:10.1055/a-2336-1062.

Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management.

Beltrami-Moreira M, Sharma A, Bussel JB

Expert review of hematology 2024; (17(9)):595-607 doi:10.1080/17474086.2024.2385481.

The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?

Saldanha A, Colella MP, Villaça PR, et al.

Thrombosis research 2024; (241()):109109 doi:10.1016/j.thromres.2024.109109.

[Management of pediatric immune thrombocytopenia].

Mori M

[Rinsho ketsueki] The Japanese journal of clinical hematology 2024; (65(9)):1209-1215 doi:10.11406/rinketsu.65.1209.

Immune Thrombocytopenic Purpura and Maternal and Neonatal Outcomes During Pregnancy: A Systematic Review and Meta-Analysis.

Zhang H, Shi L, Shang H, Yang H

American journal of reproductive immunology (New York, N.Y. : 1989) 2024; (92(5)):e70008 doi:10.1111/aji.70008.

The Effect of COVID-19 on Platelet Counts in Persistent and Chronic Adult ITP Patients: A Real-World Study in China.

Zhang Y, Yang L, Xu Z, Zhou X

EJHaem 2025; (6(2)):e70025 doi:10.1002/jha2.70025.

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study.

Sirotich E, Chowdhury SR, Modi D, et al.

Blood advances 2025; (9(13)):3238-3248 doi:10.1182/bloodadvances.2024015494.

Refractory Immune Thrombocytopenic Purpura With Low Immature Platelet Fraction.

Ali K, Scotto T, Williams JM, Reddy P

Cureus 2025; (17(4)):e82533 doi:10.7759/cureus.82533.

Natural killer cell granule protein 7 contributes to CD8+ T cell-mediated platelet apoptosis in immune thrombocytopenia.

Wang X, Liu Q, Li X, et al.

Research and practice in thrombosis and haemostasis 2025; (9(5)):102977 doi:10.1016/j.rpth.2025.102977.

Treatment options for immune thrombocytopenia (ITP) in pregnancy and postpartum.

Merz LE, Fogerty AE

Expert opinion on pharmacotherapy 2025; (26(13)):1441-1449 doi:10.1080/14656566.2025.2557448.

A Case of Cerebral Venous Sinus Thrombosis Following Eltrombopag in Immune Thrombocytopenia.

Raja T, Jesiah N, Mayurathan P, Kugathasan A

Cureus 2025; (17(11)):e96811 doi:10.7759/cureus.96811.

Influence of Anxiety Level and Degree of Alexithymia on Quality of Life in Adult Patients With Primary Immune Thrombocytopenia.

Liang S, Wu T, Chai L, et al.

Actas espanolas de psiquiatria 2025; (53(6)):1274-1285 doi:10.62641/aep.v53i6.2026.

Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France.

Therme F, Viallard JF, Rueter M, et al.

American journal of hematology 2026; (101(3)):456-466 doi:10.1002/ajh.70192.

Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelines.

Gunn E, Angulo PA, Badawy SM, et al.

Blood advances 2026; (10(9)):3304-3312 doi:10.1182/bloodadvances.2025018690.

A Clinician Perspective for a Personalized Approach to Management of Chronic Immune Thrombocytopenia with Targeted Therapies Alone or in Combination.

Mingot-Castellano ME, Lambert MP, Bowhay-Carnes E

Journal of clinical medicine 2026; (15(4)) doi:10.3390/jcm15041625.

Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.

Zordan J, Zadro Y, Sommet A, et al.

Journal of thrombosis and haemostasis : JTH 2026; (24(7)):2567-2578 doi:10.1016/j.jtha.2026.04.002.

Primary Versus Secondary Immune Thrombocytopenia in Adults: A Comparative Analysis of Clinical and Laboratory Parameters in Newly Diagnosed ITP Patients from North India.

Sandal R, Jandial A, Mishra K, et al.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2026; (42(4)):1302-1311 doi:10.1007/s12288-025-02119-3.

Diagnosing Immune Thrombocytopenia: An Update.

Cooper N, Sachs UJ

Hamostaseologie 2026; doi:10.1055/a-2926-8391.